The Federal Trade Commission and U.S. Justice Department’s proposed merger guidelines could slow the rapid pace of acquisitions and consolidations in the health care industry, antitrust lawyers said this week.  

The draft guidelines, released in July, are designed to ensure acquisitions do not harm competition in the market, reflecting the Biden administration’s stated goal of aggressive oversight of planned corporate mergers.